Lannett Co., Inc.
(NYSE : LCI)

( )
LCI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.09%130.110.7%$909.56m
PFEPfizer Inc.
0.00%36.510.9%$710.82m
MRKMerck & Co., Inc.
0.01%83.970.7%$606.49m
ABBVAbbVie, Inc.
0.00%71.672.3%$520.62m
BMYBristol-Myers Squibb Company
0.00%50.071.4%$447.62m
LLYEli Lilly and Company
1.45%114.351.0%$345.69m
AZNAstraZeneca PLC Sponsored ADR
1.57%45.291.2%$149.60m
NVSNovartis AG Sponsored ADR
1.84%87.980.2%$133.07m
GSKGlaxoSmithKline plc Sponsored ADR
1.20%41.820.3%$83.57m
NVONovo Nordisk A/S Sponsored ADR Class B
0.02%51.890.1%$73.01m
SNYSanofi Sponsored ADR
1.45%45.570.2%$55.42m
LCILannett Company, Inc.
-4.21%13.4135.6%$51.71m
AKTXAkari Therapeutics Plc Sponsored ADR
0.00%1.931.6%$2.11m
EPIXESSA Pharma Inc
7.02%3.050.1%$0.19m

Company Profile

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. Its products include aqueous vitamin D 4; escitalopram oxalate; ranitidine syrup; danazol; primidone; and isonlazid. The company was founded in 1942 and is headquartered in Philadelphia, PA.